GO:0071305 cellular response to vitamin D: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071305 describes how a single cell changes its state or activity in response to vitamin D, including movement, secretion, enzyme production and gene expression.
• The term covers both genomic (VDR-mediated transcription) and rapid, non-genomic responses to calciferol, cholecalciferol and ergocalciferol.
• Vitamin D can both facilitate and attenuate cellular responses to lipopolysaccharide, showing context-dependent immune modulation.
• In vivo vitamin D exposure remodels the human epigenome and the white blood cell transcriptome, providing direct evidence for GO:0071305 in humans.
• Vitamin D enhances antiviral responses in dengue virus-infected macrophages by modulating early-response gene expression.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test causality of genes acting within GO:0071305.
Description
GO:0071305, cellular response to vitamin D, is a biological process Gene Ontology term defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus. Vitamin D is a secosteroid hormone whose active form, 1,25-dihydroxyvitamin D3, acts through the vitamin D receptor (VDR) to reprogram gene expression in many cell types, and this reprogramming is the core of the cellular response captured by GO:0071305. Because the term is deliberately broad, it encompasses rapid non-genomic signaling events as well as slower transcriptional and epigenetic changes that occur after vitamin D exposure. Researchers use GO:0071305 to annotate datasets from immune, placental, macrophage and white blood cell systems where vitamin D is a stimulus. The term is therefore a useful anchor for comparing vitamin D responses across cell types and for interpreting transcriptomic, proteomic and epigenomic experiments.
cellular response to vitamin D At A Glance
| GO ID | GO:0071305 |
|---|---|
| GO term | cellular response to vitamin D |
| Ontology | biological_process |
| Synonym | cellular response to calciferol; cellular response to cholecalciferol; cellular response to ergocalciferol |
| Definition | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus. |
| Major function | Mediates cellular adaptation to vitamin D, including gene expression, secretion and enzyme production changes. |
| Stimulus | Vitamin D and its active metabolites such as calciferol, cholecalciferol and ergocalciferol. |
| Key mediator | Vitamin D receptor (VDR) and associated chromatin-modifying complexes. |
| Evidence in humans | In vivo epigenome and white blood cell transcriptome responses to vitamin D. |
What Is GO:0071305?
In our own words, GO:0071305 captures every cellular change triggered by a vitamin D stimulus. It includes changes in cell movement, secretion, enzyme production and gene expression, and it applies to any cell type that can sense vitamin D. The term is intentionally broad so that it can cover both rapid signaling events and long-term transcriptional or epigenetic reprogramming.
Why Is cellular response to vitamin D Important in Cell Biology?
GO:0071305 matters because vitamin D is not merely a nutrient; it is a hormone-like regulator of immune, placental, macrophage and white blood cell function, and the cellular response to vitamin D determines whether those cells mount, modulate or resolve a response. Understanding this term helps researchers interpret why vitamin D can both facilitate and attenuate inflammatory signaling, and why its effects differ between cell types and disease contexts.
• Vitamin D modulates the immune response to respiratory viruses, making GO:0071305 relevant to antiviral defense.
• Vitamin D can both facilitate and attenuate the cellular response to lipopolysaccharide, highlighting context-dependent immune regulation.
• In dengue virus-infected macrophages, vitamin D enhances antiviral responses by modulating early-response gene expression.
• In vivo vitamin D exposure changes the human epigenome, linking GO:0071305 to chromatin-level regulation.
• In vivo transcriptome changes in human white blood cells provide direct evidence for GO:0071305 in circulating immune cells.
• Placental trophoblast proteomes respond to vitamin D, connecting GO:0071305 to pregnancy biology.
• Silencing of PDIA3 alters proliferation, migration and genes controlling active vitamin D, showing that GO:0071305 can be modulated by intracellular proteins.
• GO:0071305 is a useful annotation target for RNA-seq, proteomics and epigenomics studies of vitamin D action.
• The term supports cross-species and cross-cell-type comparisons of vitamin D responsiveness.
• CRISPR-based models allow causal testing of genes that mediate or modify GO:0071305.
What Happens During cellular response to vitamin D?
Vitamin D sensing and receptor engagement
In simple terms: The cell first detects vitamin D, usually through the vitamin D receptor.
The cellular response to vitamin D begins when a vitamin D stimulus is sensed by the cell, most commonly through the vitamin D receptor (VDR), which binds active vitamin D metabolites and initiates downstream changes. This sensing step is the entry point for GO:0071305 and determines whether the cell will undergo genomic or non-genomic responses.
Genomic transcriptional reprogramming
In simple terms: The cell switches many genes on or off after vitamin D arrives.
A major component of GO:0071305 is transcriptional reprogramming. In vivo vitamin D exposure changes the human epigenome, and white blood cell transcriptomes shift after vitamin D treatment, demonstrating that vitamin D alters gene expression programs in circulating cells. These changes underlie the broad definition of the term, which explicitly includes gene expression.
Immune and inflammatory modulation
In simple terms: Vitamin D can dial immune responses up or down depending on the situation.
Vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide, showing that GO:0071305 can tune inflammatory signaling rather than simply suppress or activate it. Vitamin D also modulates the immune response to respiratory viruses, further supporting a context-dependent role for this process.
Antiviral and early-response gene expression
In simple terms: In infected cells, vitamin D can boost early antiviral genes.
In dengue virus-infected macrophages, vitamin D enhances antiviral responses by modulating early-response gene expression, directly linking GO:0071305 to antiviral cell states. This illustrates that the cellular response to vitamin D can reshape how a cell reacts to a pathogen.
Tissue-specific responses: placental trophoblasts
In simple terms: Different tissues respond to vitamin D in their own way.
Comparative proteomic analysis of placental trophoblasts from normotensive and preeclamptic pregnancies shows that trophoblast cells respond to vitamin D with distinct protein changes. This demonstrates that GO:0071305 is not restricted to immune cells and can be studied in reproductive tissues.
Modulation by intracellular proteins such as PDIA3
In simple terms: Other proteins inside the cell can change how strongly the cell responds to vitamin D.
Silencing of PDIA3 affects proliferation, migration and genes that control active vitamin D, indicating that intracellular proteins can modulate the cellular response to vitamin D. This places GO:0071305 within a broader regulatory network rather than an isolated pathway.
Key Genes Involved in GO:0071305 cellular response to vitamin D
The following genes and proteins are recurrently implicated in the cellular response to vitamin D and in studies that annotate or perturb GO:0071305.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VDR | Vitamin D receptor; binds active vitamin D and initiates transcriptional responses | Central mediator of GO:0071305; target for KO and point-mutation studies |
| PDIA3 | Protein disulphide-isomerase A3; influences proliferation, migration and genes controlling active vitamin D | Silencing alters cellular responses to vitamin D, making it a modifier of GO:0071305 |
| CYP27B1 | Enzyme that produces active vitamin D metabolites | Determines local availability of the vitamin D stimulus for GO:0071305 |
| CYP24A1 | Enzyme that degrades active vitamin D | Feedback regulator that limits the duration of GO:0071305 |
| RXRA | Retinoid X receptor alpha; heterodimer partner for VDR | Required for genomic vitamin D signaling within GO:0071305 |
| NCOA1 | Nuclear receptor coactivator 1 | Coactivator that supports VDR-driven transcription in GO:0071305 |
| NCOR1 | Nuclear receptor corepressor 1 | Corepressor that restrains VDR target genes in GO:0071305 |
| KDM6B | Histone demethylase involved in chromatin remodeling | Epigenome remodeling after vitamin D exposure supports GO:0071305 |
| KDM4A | Histone demethylase linked to chromatin changes | Epigenomic response to vitamin D in vivo |
| IL6 | Cytokine whose expression is modulated by vitamin D | Readout of immune modulation within GO:0071305 |
| TNF | Cytokine whose expression is modulated by vitamin D | Readout of inflammatory modulation within GO:0071305 |
| IL1B | Cytokine whose expression is modulated by vitamin D | Readout of inflammatory modulation within GO:0071305 |
| CXCL10 | Chemokine involved in antiviral and immune responses | Early-response gene modulated by vitamin D in macrophages |
| IFNB1 | Type I interferon involved in antiviral responses | Antiviral readout of GO:0071305 in infected macrophages |
| ISG15 | Interferon-stimulated gene with antiviral activity | Antiviral readout of GO:0071305 |
| CAMP | Cathelicidin antimicrobial peptide; classical vitamin D target | Canonical marker of vitamin D transcriptional response |
| DEFB4A | Beta-defensin 4A; antimicrobial peptide | Immune readout of vitamin D response |
| TLR2 | Toll-like receptor 2; innate immune sensor | Links vitamin D response to microbial sensing |
How Is cellular response to vitamin D Regulated?
The cellular response to vitamin D is regulated at multiple levels. Locally, CYP27B1 and CYP24A1 control the availability and degradation of active vitamin D, thereby setting the strength and duration of the stimulus. At the chromatin level, in vivo vitamin D exposure remodels the human epigenome, indicating that histone-modifying enzymes and chromatin accessibility shape which genes can respond. Intracellular proteins such as PDIA3 can also modulate proliferation, migration and genes controlling active vitamin D, showing that the response is embedded in a broader regulatory network. In immune cells, the response is further tuned by the inflammatory context, as vitamin D can both facilitate and attenuate lipopolysaccharide responses.
cellular response to vitamin D and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VDR | Vitamin D-dependent immune and metabolic disorders | VDR knockout and point-mutation cell lines |
| PDIA3 | Proliferation and migration phenotypes linked to vitamin D action | PDIA3 silencing or knockout in vitamin D-treated cells |
| CYP24A1 | Disorders of vitamin D catabolism | CYP24A1 knockout and overexpression models |
| CXCL10 | Antiviral and inflammatory responses | Macrophage knock-in reporters for early-response genes |
| IL6 | Inflammatory modulation | LPS-stimulated immune cells with vitamin D treatment |
Infectious and antiviral disease
Vitamin D modulates the immune response to respiratory viruses, and in dengue virus-infected macrophages it enhances antiviral responses by modulating early-response gene expression. These findings link GO:0071305 to antiviral defense and suggest that the cellular response to vitamin D can influence infection outcomes.
Inflammatory and immune-mediated conditions
Because vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide, dysregulation of GO:0071305 may contribute to unbalanced inflammatory responses. Vitamin D and the immune system are broadly connected, supporting the relevance of this term to immune-mediated conditions.
Pregnancy disorders including preeclampsia
Comparative proteomic analysis of placental trophoblasts from normotensive and preeclamptic pregnancies in response to vitamin D shows that trophoblast responses differ by disease state. This connects GO:0071305 to placental biology and preeclampsia research.
Disorders of vitamin D metabolism and action
Silencing of PDIA3 affects proliferation, migration and genes in control of active vitamin D, indicating that proteins outside the classical VDR pathway can influence GO:0071305. Such modifiers may be relevant to disorders where vitamin D action is altered.
From cellular response to vitamin D-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is VDR required for the cellular response to vitamin D? | VDR knockout cell line |
| Does a specific VDR variant alter transcriptional output? | VDR point-mutation knock-in |
| Which genes are direct targets of vitamin D signaling? | Tagged knock-in of VDR followed by chromatin and transcriptomic assays |
| Does PDIA3 modify the response to vitamin D? | PDIA3 knockout or silencing |
| Can vitamin D enhance antiviral gene expression? | Macrophage overexpression or reporter knock-in of early-response genes |
| How does vitamin D affect placental trophoblast proteins? | Trophoblast proteomics with vitamin D treatment |
How to Study the cellular response to vitamin D Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Transcriptome response to vitamin D in white blood cells |
| Epigenomic profiling | Chromatin accessibility and histone modifications | In vivo epigenome response to vitamin D |
| Proteomics | Protein abundance and modifications | Trophoblast response to vitamin D |
| qPCR | Expression of selected target genes | Validation of vitamin D-responsive genes |
| CRISPR knockout | Loss-of-function effects | Testing VDR or PDIA3 requirement |
| CRISPR knock-in | Tagged or variant protein expression | Tracking VDR complexes and variants |
| Migration assay | Cell movement | PDIA3 silencing effects on migration |
| Antiviral assay | Viral replication and interferon response | Dengue virus-infected macrophages treated with vitamin D |
Transcriptomics and RNA-seq
RNA-seq measures global gene expression changes after vitamin D exposure and is directly aligned with the gene expression component of GO:0071305. In vivo transcriptome changes of human white blood cells in response to vitamin D provide a template for this approach.
Epigenomics and chromatin profiling
In vivo response of the human epigenome to vitamin D demonstrates that chromatin-level assays can capture the regulatory layer of GO:0071305. These methods help identify which genomic regions become accessible or modified after vitamin D treatment.
Proteomics
Comparative proteomic analysis of placental trophoblasts in response to vitamin D shows how protein-level changes can be mapped to GO:0071305. Proteomics complements transcriptomics by capturing enzyme production and secretion changes.
Functional perturbation and imaging
Silencing of PDIA3 and assessment of proliferation and migration illustrate how functional assays test the role of specific proteins in the cellular response to vitamin D. Imaging and migration assays can be combined with vitamin D treatment to study cell movement and secretion.
How CRISPR Can Be Used to Study GO:0071305 cellular response to vitamin D
Knockout
CRISPR knockout of VDR or PDIA3 can test whether these genes are required for the cellular response to vitamin D. Loss-of-function models help distinguish causal mediators from correlative markers within GO:0071305.
Point Mutation
Point-mutation knock-in of VDR or its partners can reveal how specific residues affect transcriptional and non-genomic responses to vitamin D. Such models are useful when a disease-associated variant is suspected to alter GO:0071305.
Knock-in
Tagged knock-in of VDR or early-response genes allows tracking of protein complexes and regulatory elements after vitamin D exposure. Knock-in reporters can also quantify antiviral gene activation in macrophages.
Overexpression
Overexpression of vitamin D-metabolizing enzymes such as CYP27B1 or of antiviral effectors can amplify or reshape the cellular response to vitamin D. These models are useful for gain-of-function studies within GO:0071305.
How EDITGENE Supports cellular response to vitamin D Research
Researchers studying cellular response to vitamin D-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. CRISPR-based perturbation provides that causal link by removing, mutating, tagging or overexpressing the gene of interest in a controlled cellular background.
Contact EDITGENE today to design your custom CRISPR model for cellular response to vitamin D research.
Frequently Asked Questions About cellular response to vitamin D
What is GO:0071305 cellular response to vitamin D?
GO:0071305 is a biological process Gene Ontology term describing any change in a cell's state or activity, such as movement, secretion, enzyme production or gene expression, caused by a vitamin D stimulus.
What genes are involved in the cellular response to vitamin D?
Key genes include VDR, PDIA3, CYP27B1, CYP24A1, RXRA and immune effectors such as CXCL10 and ISG15, based on published studies of vitamin D responses.
How does vitamin D change gene expression in cells?
Vitamin D exposure remodels the epigenome and changes white blood cell transcriptomes, leading to altered expression of many target genes.
Can vitamin D both increase and decrease immune responses?
Yes, vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide, showing context-dependent immune modulation.
Does vitamin D affect antiviral responses?
Vitamin D enhances antiviral responses in dengue virus-infected macrophages by modulating early-response gene expression.
What methods are used to study cellular response to vitamin D?
Common methods include RNA-seq, epigenomic profiling, proteomics, qPCR, CRISPR knockout and knock-in, migration assays and antiviral assays.
How is PDIA3 related to vitamin D responses?
Silencing of PDIA3 affects proliferation, migration and genes in control of active vitamin D, indicating it can modulate the cellular response to vitamin D.
Is the cellular response to vitamin D relevant to pregnancy?
Yes, comparative proteomic analysis of placental trophoblasts from normotensive and preeclamptic pregnancies shows trophoblast responses to vitamin D differ by disease state.
What CRISPR models are useful for studying GO:0071305?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression models of VDR, PDIA3 and related genes are useful for causal studies.
Why is GO:0071305 important for researchers?
It provides a standardized way to annotate and compare vitamin D-induced cellular changes across immune, placental and other cell types, supporting reproducible research.
Conclusion
GO:0071305, cellular response to vitamin D, is a broad but well-defined biological process that captures how cells change after vitamin D exposure, from gene expression and epigenome remodeling to immune and antiviral modulation. Published studies in white blood cells, macrophages, placental trophoblasts and PDIA3-silenced cells show that this response is cell-type specific and context dependent. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with transcriptomics, epigenomics and proteomics, provide the tools needed to move from correlation to causation in this field.
References
- 1. Aranow C. 2011. Vitamin D and the immune system.. J Investig Med 59(6):881-6 PMID: 21527855
- 2. Chen L et al.. 2017. Vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide.. Sci Rep 7:45172 PMID: 28345644
- 3. Greiller CL et al.. 2015. Modulation of the immune response to respiratory viruses by vitamin D.. Nutrients 7(6):4240-70 PMID: 26035247
- 4. Tamayo-Molina YS et al.. 2025. Vitamin D enhances antiviral responses in dengue virus-infected macrophages by modulating early-response gene expression.. PLoS One 20(8):e0330751 PMID: 40839599
- 5. Xu J et al.. 2025. Comparative proteomic analysis of placental trophoblasts from normotensive and preeclamptic pregnancies in response to vitamin D.. Placenta 171:130-139 PMID: 41037839
- 6. Carlberg C et al.. 2018. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study.. J Steroid Biochem Mol Biol 180:142-148 PMID: 29317287
- 7. Kermpatsou D et al.. 2024. Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): Effects on proliferation, migration, and genes in control of active vitamin D.. J Steroid Biochem Mol Biol 240:106497 PMID: 38460707
- 8. Neme A et al.. 2019. In vivo transcriptome changes of human white blood cells in response to vitamin D.. J Steroid Biochem Mol Biol 188:71-76 PMID: 30537545
